Related Experiment Video
Updated: Jan 4, 2026

11:31
Evaluation of the Storage Stability of Extracellular Vesicles
Published on: May 22, 2019
14.9K
Extracellular Vesicles as Messengers in Atherosclerosis
Mengna Peng1, Xinfeng Liu1, Gelin Xu2
1Department of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, China.
Journal of Cardiovascular Translational Research
|October 31, 2019
Summary
Extracellular vesicles (EVs) play a dual role in atherosclerosis, potentially promoting or inhibiting the disease. Monitoring circulating EVs may aid in diagnosing and grading atherosclerosis.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Biochemistry
Background:
- Atherosclerosis is a primary driver of cardiovascular diseases.
- Cells implicated in atherosclerosis release extracellular vesicles (EVs).
- EV production is modulated by both detrimental (hypoxia, oxidative stress) and beneficial (laminar flow) factors.
Purpose of the Study:
- To review the role of EVs in atherogenesis and atheroprotection.
- To explore the potential of EVs in managing atherosclerotic diseases.
Main Methods:
- Literature review of studies on extracellular vesicles and atherosclerosis.
- Analysis of EV composition (proteins, nucleic acids) and function.
- Examination of the association between circulating EV levels and atherosclerosis severity.
Main Results:
- EVs mediate cell-to-cell communication and can influence atherogenesis.
- Circulating EV levels correlate with the presence, progression, and severity of atherosclerosis.
- EVs demonstrate potential for both promoting and inhibiting atherosclerotic processes.
Conclusions:
- Extracellular vesicles are key players in the development and progression of atherosclerosis.
- EVs hold promise as diagnostic biomarkers and therapeutic targets for atherosclerotic diseases.
Related Concept Videos
Atherosclerosis I: Introduction
723
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Inflammation
61.3K
Overview
61.3K
Coronary Artery Disease II: Pathophysiology
325
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
325
Atherosclerosis III: Management
286
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
286
Receptor-mediated Endocytosis
110.2K
Overview
110.2K

